Cooley Defeats Preliminary Injunction for Liquidia in Litigation With United Therapeutics
June 04, 2024
June 04, 2024
PALO ALTO, California, June 4 -- Cooley, a law firm, issued the following news release:
Cooley successfully defeated a preliminary injunction filed by United Therapeutics that sought to block the launch of client Liquidia's Yutrepia (treprostinil) inhalation powder for the treatment of pulmonary hypertension associated with interstitial lung disease.
United Therapeutics filed suit in September 2023, alleging Yutrepia would infringe US Patent No. 11,826,327. The denial o . . .
Cooley successfully defeated a preliminary injunction filed by United Therapeutics that sought to block the launch of client Liquidia's Yutrepia (treprostinil) inhalation powder for the treatment of pulmonary hypertension associated with interstitial lung disease.
United Therapeutics filed suit in September 2023, alleging Yutrepia would infringe US Patent No. 11,826,327. The denial o . . .